Medicines / Astrazeneca Pharma India / Imfinzi
ImfinziDurvalumab
Imfinzi is marketed by Astrazeneca Pharma India. 2 packs on NPPA's price list for July 2026, containing Durvalumab.
- Packs listed
- 2
- Lowest MRP
- ₹40,791
- Per unit
- ₹17,132 to ₹20,395
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹171,324Imfinzi 500 mg Injection 10 mlDurvalumab Injection 500 mg · ₹17,132 per ml
- ₹40,791Imfinzi 120 mg Injection 2.4 mlDurvalumab Injection 120 mg · ₹20,395 per ml
The company
Astrazeneca Pharma India has 57 packs on the price list. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.